Star Equity Holdings, Inc. Adds Richard Coleman as Chief Operating Officer
OLD GREENWICH, Conn., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR;…
5 years ago
EXL acquires Clairvoyant, adding scale in data, AI, and cloud engineering to fast-growing analytics business
Investment accelerates EXL’s data-driven strategy by expanding key capabilities and strategic relationships NEW YORK, Dec.…
5 years ago
CORRECTING and REPLACING Chengdu Wins the Bid to Host 81st World Science Fiction Convention (2023 Worldcon)
WASHINGTON--(BUSINESS WIRE)--#Chengdu--Please replace the release dated December 19, 2021 with the following corrected version due…
5 years ago
Wipro to Acquire Edgile to Strengthen its Leadership in Strategic Cybersecurity Services
Acquisition will address fast-growing demand for cybersecurity consulting among Global 2000 enterprises BANGALORE, India &…
5 years ago
CG Oncology Announces First Patient Dosed in Japan in Phase 3 Monotherapy Study of CG0070 in Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin
- Company Receives $10 Million Milestone Payment from Kissei Pharmaceutical Co., Ltd. - IRVINE, Calif.--(BUSINESS…
5 years ago
Stronghold Digital Mining Acquires 9,080 Bitcoin Miners and Secures $54 Million Equipment Financing
NEW YORK, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Stronghold Digital Mining, Inc. (Nasdaq: SDIG) (“Stronghold”,…
5 years ago
Bloom Energy to Power India’s First Green Hydrogen Microgrid
New project with the Indian Ministry of Power will showcase Bloom’s hydrogen and power production…
5 years ago
Bloom Energy to Power India’s First Green Hydrogen Microgrid
New project with the Indian Ministry of Power will showcase Bloom’s hydrogen and power production…
5 years ago
China Genetic Testing Market to 2026 – by Test Type, Disease, Technology, Service Provider and Testing Sample – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "China Genetic Testing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026"…
5 years ago
BeiGene Expands Collaboration with Novartis to Develop and Commercialize BeiGene’s TIGIT Inhibitor and Market Five Novartis Oncology Medicines in China Broad Markets
Strategic collaboration expected to advance clinical development of ociperlimab in combination with tislelizumab, including initiation…
5 years ago